Navigation Links
Data Sciences International acquires Buxco Research Company to expand preclinical research solutions offering
Date:1/7/2014

ST. PAUL, Minn., Jan. 7, 2014 /PRNewswire/ -- Data Sciences International (DSI) announces it has acquired Buxco Research Company. The acquisition will combine Buxco's expertise in preclinical pulmonary research with DSI's leadership in designing and manufacturing implantable telemetry devices to provide researchers a world class physiologic monitoring solution.  The companies' combined capabilities will support greater productivity for cardiopulmonary researchers.

(Logo: http://photos.prnewswire.com/prnh/20140107/CG40863LOGO)

The transaction will create an unrivaled leader in serving the preclinical physiologic monitoring market. The combination builds on both companies' technological strengths to accelerate results for life sciences customers working in cardiovascular and pulmonary research.

"We are extremely excited about this acquisition because it helps DSI realize our vision of being a solutions provider for our customers and creates significant value for our shareholders," said Bert Harman chief executive officer for DSI. "Our customers will now be able to achieve even higher levels of productivity by working with DSI. For our shareholders, we expect the transaction to generate attractive financial returns."

ABOUT DSI
DSI is a pioneering biomedical research company focused on pre-clinical systems physiology and pharmacology. The recognized global leader in physiologic monitoring, DSI offers telemetry, instrumentation, software and services that help advance science. DSI serves many industries including: Pharmaceuticals, Academia, Contract Research Organizations, Biological and Chemical Defense, the Medical Device Industry, Government, and Biotechnology companies. Solutions are tailored specifically to meet the unique research needs of their customers.

Visit http://www.datasci.com for more about the company.

Media Contact:

Dave Johnson


(651)-414-5400


djohnson@datasci.com


'/>"/>
SOURCE Data Sciences International
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
5. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
6. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
7. Neurocrine Biosciences Reports First Quarter 2012 Results
8. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
9. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
10. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
11. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):